Hindustan Bio Sciences Limited operates in pharmaceutical and biotechnology sectors in India. It offers recombinant human erythropoietien drug. The company also manufactures and markets a range of finished dosage forms of pharmaceutical products, including dry and liquid injectables, liquid/dry syrups, eye/ear/nasal drops, and pre-filled syringes, as well as non-sterile/sterile ointments, tablets, and capsules. In addition, it engages in the trading of drugs and medicines. The company also exports its products. The company was incorporated in 1991 and is based in Hyderabad, India.
Metrics to compare | HISO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHISOPeersSector | |
---|---|---|---|---|
P/E Ratio | 35.8x | −2.5x | −0.6x | |
PEG Ratio | 0.10 | 0.00 | 0.00 | |
Price/Book | 11.7x | 2.4x | 2.6x | |
Price / LTM Sales | 6.3x | 7.6x | 3.1x | |
Upside (Analyst Target) | - | 61.3% | 56.8% | |
Fair Value Upside | Unlock | −15.2% | 7.7% | Unlock |